Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.

Lang JE, Holbrook JT, Mougey EB, Wei CY, Wise RA, Teague WG, Lima JJ, American Lung Association-Airways Clinical Research Centers.

Open source

DOI
10.1513/annalsats.201408-391oc
Published
2015-06-01
Container
Ann Am Thorac Soc
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1513/annalsats.201408-391oc,
  title = {Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.},
  author = {Lang JE and  Holbrook JT and  Mougey EB and  Wei CY and  Wise RA and  Teague WG and  Lima JJ and  American Lung Association-Airways Clinical Research Centers.},
  year = {2015},
  journal = {Ann Am Thorac Soc},
  doi = {10.1513/annalsats.201408-391oc},
  url = {https://doi.org/10.1513/annalsats.201408-391oc}
}

RIS

TY  - JOUR
TI  - Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.
AU  - Lang JE
AU  -  Holbrook JT
AU  -  Mougey EB
AU  -  Wei CY
AU  -  Wise RA
AU  -  Teague WG
AU  -  Lima JJ
AU  -  American Lung Association-Airways Clinical Research Centers.
PY  - 2015
JO  - Ann Am Thorac Soc
DO  - 10.1513/annalsats.201408-391oc
UR  - https://doi.org/10.1513/annalsats.201408-391oc
ER  - 

APA

JE, L., JT, H., EB, M., CY, W., RA, W., WG, T., JJ, L., & Centers., A. L. A. C. R. (2015). Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype.. Ann Am Thorac Soc. https://doi.org/10.1513/annalsats.201408-391oc

Source records